Skip to main content
. 2023 Nov 16;11(11):3073. doi: 10.3390/biomedicines11113073

Figure 1.

Figure 1

In the discovery phase, miRNAs with differential expression were identified in patients with prostate cancer. Group X1-X1.22 included late-stage prostate cancer tissues, while group X2-X2.22 included early-stage prostate cancer tissues.